Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using α-interferon

European Journal of Pediatric Surgery

Volumn 16, Issue 5, 2006, Pages 369-372

  Harper, Luke ^a,c   Michel, J L ^a   Enjolras, O ^b   Raynaud Mounet, N ^a   Riviere J P ^a   Heigele, T ^a   De Napoli Cocci, S ^a  

^a Centre Hospitalier Departemental Felix Guyon   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c HÔPITAL PELLEGRIN   (France)

Author keywords

interferon; Kaposiform hemangioendothelioma; Kasabach Merritt syndrome

Indexed keywords

ALPHA INTERFERON; VINCRISTINE;

ABDOMINAL RADIOGRAPHY; ARTICLE; BODY REGIONS; CASE REPORT; CELL PROLIFERATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; HEMANGIOENDOTHELIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFANT; KASABACH MERRITT SYNDROME; LIVER CELL DAMAGE; MALE; MORTALITY; RETROPERITONEAL CANCER; SPINDLE CELL; THROMBOCYTE COUNT; TREATMENT DURATION;

ANGIOGENESIS INHIBITORS; DISSEMINATED INTRAVASCULAR COAGULATION; HEMANGIOENDOTHELIOMA; HUMANS; INFANT; INTERFERON-ALPHA; MALE; PLATELET COUNT; THROMBOCYTOPENIA;

EID: 33845311809     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924615     Document Type: Article

References (24)

1. Aylett SE, Williams AF, Bvan DH et al. The Kasabach-Merritt syndrome: treatment with intermittent pneumatic compression. Arch Dis Child 1990; 65: 790-791
2. Barlow CF, Priebe CJ, Mulliken JB et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998; 132: 527-530
3. Brasanac D, Janic D, Boricic I et al. Retroperitoneal kaposiform hemangioendothelioma with tufted angioma-like features in an infant with Kasabach-Merritt syndrome. Pathol Int 2003; 53: 627-631
4. Caldwell JB, Ryan MT, Benson PM et al. Cutaneous sarcoma arising in the radiation site of a congenital hemangioma. J Am Acad Dermatol 1995; 33: 865-870
5. Deb G, Jenkner A, De Sio L et al. Spindle cell (kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with a 2A interferon. Med Ped Oncol 1997; 28: 358-361
6. De Prost Y, Teillac D, Bodemer C et al. Successful treatment of Kasabach-Merritt syndrome with pentoxifylline. J Am Acad Dermatol 1991; 25: 854-855
7. Drolet BA, Scott LA, Esterly NB et al. Early surgical intervention in a patient with Kasabach-Merritt phenomenon. J Pediatr 2001; 138: 756-758
8. El-Dessouky M, Azmy AF, Raine PA et al. Kasabach-Merritt syndrome. J Pediatr Surg 1988; 23: 109-111
9. Enjolras O, Wassef M, Mazoyer E et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangioma. J Pediatr 1997; 130: 631-640
10. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992; 28: 1456-1463
11. Haisly-Royster C, Enjolras O, Frieden IJ et al. Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Haematol 2002; 24: 459-462
12. Hatley RM, Sabio H, Howell CG et al. Successful management of an infant with a giant hemangioma of the retroperitoneum and Kasabach-Merritt syndrome with alpha-interferon. J Pediatr Surg 1993; 28: 1356-1357
13. Hu B, Lachman R, Phillips J et al. Kasabach-Merritt syndrome - associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine and actinomycin D. J Pediatr Hematol 1998; 20: 567-569
14. Inglefield JT, Tisdale PT, Fairchild PT. A case of hemangioma with thrombocytopenia in the newborn treated by total excision: review of the literature. J Pediatr 1961; 59: 238-242
15. ème. Monaco: Congrès International de Dermatologie Pédiatrique, 1983: 342
16. Mulliken JB, Anupindi S, Ezekowitz RA et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-2004. A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med 2004; 22: 1764-1765
17. Nakayama H. Clinical and histological studies of the classification and the natural course of the strawberry mark. J Dermatol 1981; 8: 277-291
18. North PE, Waner M, James CA et al. Congenital non progressive hemangioma. Arch Dermatol 2002; 137: 1607-1620
19. Sadan N, Horowitz I, Choc L et al. Giant hemangioma with thrombocytopenia and osteolysis successfully treated with prednisone. J Pediatr Orthop 1989; 9: 472-475
20. Sarkar M, Mulliken JB, Kozakewich HP et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997; 100: 1377-1386
21. Shulkin BL, Argenta LC, Cho KJ et al. Kasabach-Merritt syndrome: treatment with epsilon-aminocaproic acid and assessment by indium-111 platelet scintigraphy. J Pediatr 1990; 117: 746-749
22. Stanley P, Gomperts E, Woolley MM. Kasabach-Merritt syndrome treated by therapeutic embolization with polyvinyl alcohol. Am J Pediatr Hematol Oncol 1986; 8: 308-311
23. White CW, Wolf SJ, Korones DN et al. Treatment of childhood angiomatous diseases with recombinant interferon alpha 2A. J Pediatr 1991; 118: 59-66
24. Zuckerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993; 17: 321-328